DrugDashboards

Market view

guaifenesin, phenylephrine hydrochloride and dextromethorphan hydrobromide

2 marketed package NDCs · 2 active manufacturers

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for guaifenesin, phenylephrine hydrochloride and dextromethorphan hydrobromide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Uncompetitive N-methyl-D-aspartate Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Guaifenesin, phenylephrine hydrochloride and dextromethorphan hydrobromide in shortage right now?
No. FDA does not currently list Guaifenesin, phenylephrine hydrochloride and dextromethorphan hydrobromide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Guaifenesin, phenylephrine hydrochloride and dextromethorphan hydrobromide?
2 companies have marketed Guaifenesin, phenylephrine hydrochloride and dextromethorphan hydrobromide in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.